ArticleMucosal immunology2009

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.

X Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.